Lv41
540 积分 2023-11-29 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
2小时前
已完结
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study
1个月前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
1个月前
已完结
骨骼肌松弛药临床应用专家共识(2024)
3个月前
已完结
Immunohistochemical detection of gastric mucin in normal and disease states
4个月前
已关闭
Current and Emerging Pharmacological Therapies for Cushing's Disease
4个月前
已完结
Combination of Baricitinib and Phototherapy in Adults With Active Vitiligo
4个月前
已完结
皖公网安备34019202002308
